Eugen Mengel

8.8k total citations
137 papers, 4.7k citations indexed

About

Eugen Mengel is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Eugen Mengel has authored 137 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Physiology, 42 papers in Epidemiology and 38 papers in Rheumatology. Recurrent topics in Eugen Mengel's work include Lysosomal Storage Disorders Research (126 papers), Trypanosoma species research and implications (38 papers) and Glycogen Storage Diseases and Myoclonus (36 papers). Eugen Mengel is often cited by papers focused on Lysosomal Storage Disorders Research (126 papers), Trypanosoma species research and implications (38 papers) and Glycogen Storage Diseases and Myoclonus (36 papers). Eugen Mengel collaborates with scholars based in Germany, United States and United Kingdom. Eugen Mengel's co-authors include Marie T. Vanier, Bruno Bembi, Michael Beck, Christoph Kampmann, Ashok Vellodi, Catharina Whybra, Mercè Pineda, Christian J. Hendriksz, Marc C. Patterson and Andreas Gal and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Eugen Mengel

129 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugen Mengel Germany	42	4.0k	1.3k	1.1k	1.1k	960	137	4.7k
J. E. Wraith United Kingdom	37	4.2k 1.1×	1.9k 1.5×	1.3k 1.2×	760 0.7×	573 0.6×	84	5.0k
Nathalie Guffon France	35	5.2k 1.3×	2.4k 1.9×	1.7k 1.5×	1.1k 1.0×	1.2k 1.3×	138	6.5k
Bruno Bembi Italy	43	4.2k 1.1×	1.2k 0.9×	955 0.8×	1.3k 1.2×	1.4k 1.4×	133	5.4k
Emil Kakkis United States	37	3.5k 0.9×	1.7k 1.3×	1.2k 1.0×	623 0.6×	1.1k 1.1×	73	5.0k
Anna Tylki‐Szymańska Poland	39	4.1k 1.0×	1.8k 1.5×	987 0.9×	1.2k 1.1×	1.6k 1.6×	263	5.4k
Ashok Vellodi United Kingdom	40	3.9k 1.0×	1.7k 1.3×	931 0.8×	901 0.8×	970 1.0×	105	4.9k
Rossella Parini Italy	38	3.1k 0.8×	1.3k 1.0×	1.6k 1.4×	750 0.7×	1.5k 1.5×	179	5.1k
Christian J. Hendriksz United Kingdom	34	2.8k 0.7×	1.0k 0.8×	1.0k 0.9×	434 0.4×	644 0.7×	135	3.7k
Chester B. Whitley United States	39	3.5k 0.9×	1.4k 1.1×	908 0.8×	460 0.4×	1.6k 1.7×	201	5.1k
Robin Lachmann United Kingdom	43	3.4k 0.8×	1.5k 1.2×	744 0.6×	1.0k 0.9×	1.8k 1.9×	129	6.3k

Countries citing papers authored by Eugen Mengel

Since Specialization

Citations

This map shows the geographic impact of Eugen Mengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugen Mengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugen Mengel more than expected).

Fields of papers citing papers by Eugen Mengel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugen Mengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugen Mengel. The network helps show where Eugen Mengel may publish in the future.

Co-authorship network of co-authors of Eugen Mengel

This figure shows the co-authorship network connecting the top 25 collaborators of Eugen Mengel. A scholar is included among the top collaborators of Eugen Mengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugen Mengel. Eugen Mengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scarpa, Maurizio, George A. Díaz, Roberto Giugliani, et al.. (2025). Long‐Term Safety and Clinical Outcomes With Olipudase Alfa Enzyme Replacement Therapy in Children and Adolescents With Acid Sphingomyelinase Deficiency. Journal of Inherited Metabolic Disease. 48(5). e70086–e70086.

Kampmann, Christoph, Christina Lampe, Christiane M. Wiethoff, et al.. (2024). Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapy. Journal of Inherited Metabolic Disease. 48(1). e12808–e12808.

Mengel, Eugen, et al.. (2024). A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany. Orphanet Journal of Rare Diseases. 19(1). 161–161. 3 indexed citations

Díaz, George A., Roberto Giugliani, Nathalie Guffon, et al.. (2022). Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results. Orphanet Journal of Rare Diseases. 17(1). 437–437. 28 indexed citations

Brémovà-Ertl, Tatiana, Larry A. Abel, Mark Walterfang, et al.. (2021). A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C. European Journal of Neurology. 28(9). 3040–3050. 9 indexed citations

Mengel, Eugen, et al.. (2021). Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective. Orphanet Journal of Rare Diseases. 16(1). 493–493. 6 indexed citations

Garbade, Sven F., Matthias Zielonka, Konstantin Mechler, et al.. (2020). FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis. PLoS ONE. 15(4). e0230898–e0230898. 23 indexed citations

Mengel, Eugen, et al.. (2020). The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey. PLoS ONE. 15(12). e0244279–e0244279. 9 indexed citations

Brémovà-Ertl, Tatiana, Raphael Schiffmann, Marc C. Patterson, et al.. (2018). Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings. Frontiers in Neurology. 8. 711–711. 14 indexed citations

10.

Trivedi, Jaya, Ans van der Ploeg, Richard J. Barohn, et al.. (2016). Phase 1 Safety and Pharmacokinetics of the Novel Enzyme Replacement Therapy neoGAA in Treatment-Naïve and Alglucosidase Alfa-Treated Late-Onset Pompe Disease Patients (S38.005). Neurology. 86(16_supplement). 1 indexed citations

11.

Capelle, Carine I. van, Jan C. van der Meijden, Johanna M. P. van den Hout, et al.. (2016). Childhood Pompe disease: clinical spectrum and genotype in 31 patients. Orphanet Journal of Rare Diseases. 11(1). 65–65. 47 indexed citations

12.

Kampmann, Christoph, Christina Lampe, Jörg Reinke, et al.. (2016). Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome). PLoS ONE. 11(9). e0162612–e0162612. 34 indexed citations

13.

Patterson, Marc C., Eugen Mengel, Marie T. Vanier, et al.. (2015). Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study. Orphanet Journal of Rare Diseases. 10(1). 65–65. 69 indexed citations

14.

Pastores, Gregory M., Мilan Petakov, Pilar Giraldo, et al.. (2014). A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. 53(4). 1 indexed citations

15.

Hahn, Andreas, Nesrin Karabul, Dorle Schmidt, et al.. (2014). Outcome of Patients with Classical Infantile Pompe Disease Receiving Enzyme Replacement Therapy in Germany. JIMD Reports. 20. 65–75. 47 indexed citations

16.

Patterson, Marc C., Eugen Mengel, Frits A. Wijburg, et al.. (2013). Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet Journal of Rare Diseases. 8(1). 12–12. 145 indexed citations

17.

Ru, Minke H. de, Jaap Jan Boelens, Anibh M. Das, et al.. (2011). Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet Journal of Rare Diseases. 6(1). 55–55. 177 indexed citations

18.

Lukács, Zoltán, Eugen Mengel, M. L. Beck, et al.. (2011). Dried blood spots in the diagnosis of lysosomal storage disorders—Possibilities for newborn screening and high-risk population screening. Clinical Biochemistry. 44(7). 476–476. 8 indexed citations

19.

Wendt, S., Eugen Mengel, & Martín Beck. (2006). GAUCHER DISEASE AND MISCELLANEOUS. Acta Paediatrica. 95(S451). 139–144. 1 indexed citations

20.

Manger, Bernhard, et al.. (2006). M. Gaucher, M. Fabry und Mukopolysaccharidose Typ I. Zeitschrift für Rheumatologie. 65(1). 32–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact